EUVIMEDEUVIMED entdecken
Open Access

Vascular Endothelial Growth Factor Receptors 1 and 3 Mediate Placental Trophoblast Leptin Production in Preeclampsia, Inducing Vascular Dysfunction

Mona Elgazzaz iD, Safia Ogbi, Desmond Moronge iD, Elisabeth Mellott iD, Gibson Cooper, Kristin Backer iD, Amalia Brawley iD, Gabrielle Hernendez iD, Joanna Hitchings, Luis Valesquez Zarate, Sravankumar Kavuri, Tae Jin Lee iD und 5 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026

DOI: 10.1161/atvbaha.125.324143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Mona Elgazzaz und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology (M.E., S.O., D.M., E.M., G.C., K.B., G.H., D.V.I., J.L.F.), Medical College of Georgia at Augusta University. Hauptthemen laut MEDLINE: Leptin, Pre-Eclampsia, Vascular Endothelial Growth Factor Receptor-1, Trophoblasts. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Heightened sFlt-1 (soluble FMS-like tyrosine kinase-1) level is a hallmark of preeclampsia patients and induces a state of angiogenic imbalance by sequestering free VEGF (vascular endothelial growth factor) and PlGF (placental growth factor). The receptors for VEGF and PlGF, membrane-bound VEGFR (VEGF receptor), are expressed in placental trophoblast cells, but their functions in this cell type are largely unknown. Placental production of leptin significantly increases in preeclampsia, and we recently showed that leptin induces placental and vascular endothelial dysfunction in pregnancy. We hypothesized that inappropriately high sFlt-1 in preeclampsia leads to an increase in trophoblast leptin production. METHODS: We treated human placental explants, trophoblast, and adipose cells with sFlt-1. We also infused pregnant mice with sFlt-1 via osmotic minipump from mid-late gestation. RESULTS: We show an increase in leptin peptide production, which is ablated by coadministration with either VEGF or PlGF (placental growth factor). We further demonstrate that VEGFR1 and 3, not R2, expressions are predominant in human trophoblasts and that reducing activation of these receptors mediates trophoblast leptin production. In pregnant mice, we show that sFlt-1 infusion induces vascular endothelial dysfunction in association with significantly elevated plasma leptin levels. In pregnant sFlt-1-infused mice, treatment with a leptin receptor antagonist significantly ablated vascular endothelial dysfunction. CONCLUSIONS: Collectively, these data indicate that angiogenic imbalance in preeclampsia impacts placental trophoblast endocrine function by suppressing VEGFR1 and 3 activation, resulting in leptin overproduction. Furthermore, sFlt-1 induces vascular endothelial dysfunction in mice dependent on leptin receptor activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeptinPre-EclampsiaVascular Endothelial Growth Factor Receptor-1TrophoblastsFemaleAnimalsPregnancyHumansPlacenta Growth FactorCells, CulturedReceptors, LeptinPregnancy ProteinsMice, Inbred C57BLDisease Models, AnimalVascular Endothelial Growth Factor AMiceSignal Transduction

Stichwörter der Autor:innen

adipose tissuebody mass indexfetal deathleptintrophoblasts

Substanzen

LeptinVascular Endothelial Growth Factor Receptor-1Placenta Growth FactorPGF protein, humanFLT1 protein, humanPgf protein, mouseFlt1 protein, mouseReceptors, LeptinPregnancy ProteinsVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Physiology (M.E., S.O., D.M., E.M., G.C., K.B., G.H., D.V.I., J.L.F.), Medical College of Georgia at Augusta University.
  • Department of Obstetrics and Gynecology (A.B., P.C.W., J.M., J.L.F.), Medical College of Georgia at Augusta University.
  • Department of Pathology (J.H., L.V.Z., S.K.), Medical College of Georgia at Augusta University.
  • Department of Cellular Biology and Anatomy (T.J.L.), Medical College of Georgia at Augusta University.
  • Vascular Biology Center and Department of Medicine (B.H.A.), Medical College of Georgia at Augusta University.

ORCID-Profile: Mona Elgazzaz, Desmond Moronge, Elisabeth Mellott, Kristin Backer, Amalia Brawley, Gabrielle Hernendez, Tae Jin Lee, Daria V Ilatovskaya, Padmashree C Woodham, James Maher, Brian H Annex, Jessica L Faulkner

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Elgazzaz, M., Ogbi, S., Moronge, D., Mellott, E., Cooper, G., Backer, K., Brawley, A., Hernendez, G., Hitchings, J., Valesquez Zarate, L., Kavuri, S., Lee, T. J., Ilatovskaya, D. V., Woodham, P. C., Maher, J., Annex, B. H., & Faulkner, J. L. (2026). Vascular Endothelial Growth Factor Receptors 1 and 3 Mediate Placental Trophoblast Leptin Production in Preeclampsia, Inducing Vascular Dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.324143

Vancouver

Elgazzaz M, Ogbi S, Moronge D, Mellott E, Cooper G, Backer K, et al. Vascular Endothelial Growth Factor Receptors 1 and 3 Mediate Placental Trophoblast Leptin Production in Preeclampsia, Inducing Vascular Dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.125.324143

BibTeX
@article{Elgazzaz2026,
  author = {Elgazzaz, Mona and Ogbi, Safia and Moronge, Desmond and Mellott, Elisabeth and Cooper, Gibson and Backer, Kristin and Brawley, Amalia and Hernendez, Gabrielle and Hitchings, Joanna and Valesquez Zarate, Luis and Kavuri, Sravankumar and Lee, Tae Jin and Ilatovskaya, Daria V and Woodham, Padmashree C and Maher, James and Annex, Brian H and Faulkner, Jessica L},
  title = {Vascular Endothelial Growth Factor Receptors 1 and 3 Mediate Placental Trophoblast Leptin Production in Preeclampsia, Inducing Vascular Dysfunction},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  doi = {10.1161/atvbaha.125.324143}
}
Kostenlos starten →